ATLASATLAS fair value
₩61,560
Below fair value · 59% discount
Range: ₩47,040–₩85,076Fair valuePrice
Daihan Pharmaceutical Co.Ltd (023910.KQ)
Daihan Pharmaceutical Co.Ltd stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · KOSDAQ · South Korea
₩25,200▲ 0.00%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
54%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Daihan Pharmaceutical Co.Ltd in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Daihan Pharmaceutical Co.Ltd
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Daihan Pharmaceutical Co.Ltd's fair value at about ₩61,560 per share (reasonable range: ₩47,040 to ₩85,076). At ₩25,200, the stock trades 59% below it.
It is calculated with a discounted cash-flow model. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Daihan Pharmaceutical Co.Ltd a 54% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩24,595 and ₩26,061; in 9 out of 10, between ₩23,365 and ₩27,433. Estimated annual volatility is 16%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩147B
- Market cap (USD)
- $111M
- P/E ratio
- 5.5
- Dividend yield
- 3.92%
- 52-week high
- ₩31,650
- 52-week low
- ₩24,000
- Revenue (12 months)
- ₩217B
- Gross margin
- 29.4%
- Operating margin
- 14.3%
- Net margin
- 12.7%
- Beta
- 0.15
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Daihan Pharmaceutical Co.Ltd sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 023910.KQ has traded between ₩24,000 and ₩31,650. Today it is 20.4% below that high and 5% above its low.
On the business: net margin is 12.7%; it trades at 5.5 times earnings.
Its beta is 0.15: it tends to move less than the market.
About the company
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions.
Want to see everything about Daihan Pharmaceutical Co.Ltd?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Daihan Pharmaceutical Co.Ltd (023910.KQ) fair value?
About ₩61,560 per share according to ATLAS (reasonable range: ₩47,040 to ₩85,076). With the stock at ₩25,200, it is 59% below it.
What is the chance 023910.KQ goes up next month?
54%: close to a coin flip. In half of the simulated outcomes, 023910.KQ ends the month between ₩24,595 and ₩26,061.
How big is Daihan Pharmaceutical Co.Ltd and what is its P/E ratio?
Daihan Pharmaceutical Co.Ltd's market capitalization is ₩147B. Its price-to-earnings (P/E) ratio is 5.5: you pay ₩5.46 for each ₩1.00 of yearly earnings.
Does Daihan Pharmaceutical Co.Ltd pay a dividend?
Yes. 023910.KQ's current dividend yield is 3.92% at today's price (₩25,200).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer